{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T17:36:34Z","timestamp":1789061794906,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Endosc"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Gas-bloat symptoms are common after antireflux surgery (ARS) and typically attributed to impaired gas venting from surgical changes. However, small intestinal bacterial overgrowth (SIBO), potentially linked to chronic PPI use, may also contribute. Despite this, the role of SIBO in post-ARS bloating remains underexplored. This study aimed to assess the utility of SIBO testing in patients with persistent gas-bloat symptoms after ARS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients with persistent bloating after primary ARS were offered SIBO breath testing and gastric emptying scintigraphy. Those with normal gastric emptying who completed testing were included. A gas-bloat score\u2009\u2265\u20094 on the GERD-HRQL questionnaire was considered severe. Outcomes were compared between SIBO-positive and SIBO-negative patients. SIBO-positive patients were treated with antibiotics and reassessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 71 patients with postoperative gas-bloat symptoms following ARS, 40 (56.3%) tested positive for SIBO. Compared to SIBO-negative patients, SIBO-positive patients had significantly higher postoperative gas-bloat scores (median [IQR] 4.0 [4.0\u20135.0] vs 3.0 [3.0\u20134.0],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and more frequent severe symptoms (77.5% vs 41.9%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.003), despite similar GERD-HRQL total scores, acid exposure, and satisfaction (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&gt;\u20090.05). Following antibiotic therapy, severe gas-bloat symptoms improved markedly (77.5% to 23.1%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), with corresponding reductions in gas-bloat scores (4.0 [4.0\u20135.0] to 2.0 [1.0\u20133.0],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001) and GERD-HRQL total scores (10.5 [7.0\u201319.0] to 5.0 [2.0\u201314.0], p\u2009=\u20090.002). After treatment, SIBO-positive patients had significantly better GERD-HRQL total scores than SIBO-negative patients (5.0 [2.0\u201314.0] vs 15.0 [7.0\u201326.0],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001). Satisfaction also increased from 42.5% to 69.2% (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.021). Post-treatment, SIBO-positive patients had significantly lower gas-bloat (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.004), lower regurgitation scores (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.003), and higher satisfaction (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.015) than SIBO-negative patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\u00a0SIBO was present in over half of patients with persistent bloating after ARS and was associated with more severe symptoms. Antibiotic treatment led to substantial symptom improvement and increased satisfaction. These findings suggest that SIBO testing may guide targeted therapy and improve outcomes in selected patients following antireflux surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1007\/s00464-025-12092-7","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T16:09:39Z","timestamp":1756397379000},"page":"7381-7391","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical utility of small intestinal bacterial overgrowth (SIBO) testing in guiding management of gas-bloat symptoms after antireflux surgery"],"prefix":"10.1007","volume":"39","author":[{"given":"Naveed","family":"Chaudhry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven E.","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inanc S.","family":"Sarici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsi J.","family":"Swanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Hanuschock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann M.","family":"DeWitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8113-9164","authenticated-orcid":false,"given":"Shahin","family":"Ayazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,28]]},"reference":[{"key":"12092_CR1","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1007\/s00464-012-2611-y","volume":"27","author":"LA Humphries","year":"2013","unstructured":"Humphries LA, Hernandez JM, Clark W, Luberice K, Ross SB, Rosemurgy AS (2013) Causes of dissatisfaction after laparoscopic fundoplication: the impact of new symptoms, recurrent symptoms, and the patient experience. Surg Endosc 27:1537\u20131545","journal-title":"Surg Endosc"},{"key":"12092_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f1908","author":"A Grant","year":"2013","unstructured":"Grant A, Cotton S, Boachie C, Ramsay C, Krukowski Z, Heading R, Campbell M (2013) Minimal access surgery compared with medical management for gastro-oesophageal reflux disease: five year follow-up of a randomised controlled trial (REFLUX). BMJ. https:\/\/doi.org\/10.1136\/bmj.f1908","journal-title":"BMJ"},{"key":"12092_CR3","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1001\/jama.2011.626","volume":"305","author":"J-P Galmiche","year":"2011","unstructured":"Galmiche J-P, Hatlebakk J, Attwood S, Ell C, Fiocca R, Eklund S, L\u00e5ngstr\u00f6m G, Lind T, Lundell L, Collaborators LT (2011) Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial. JAMA 305:1969\u20131977","journal-title":"JAMA"},{"key":"12092_CR4","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1097\/XCS.0000000000000928","volume":"238","author":"SE Eriksson","year":"2023","unstructured":"Eriksson SE, Ayazi S, Zheng P, Sarici IS, Hannan Z, Jobe BA (2023) Gas-bloat syndrome after magnetic sphincter augmentation: incidence, natural history, risk factors, and its impact on surgical outcomes over time. J Am College Surgeons 238:912","journal-title":"J Am College Surgeons"},{"key":"12092_CR5","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S487185","author":"Z-T Wang","year":"2025","unstructured":"Wang Z-T, Tan W-T, Huang J-L, Zhang P-F, Li Q, Wang M-M, Meng M-M, Su H, Guo C-M, Liu H (2025) Correlation between gastroesophageal reflux disease and small intestinal bacterial overgrowth: analysis of intestinal microbiome and metabolic characteristics. J Inflamm Res. https:\/\/doi.org\/10.2147\/JIR.S487185","journal-title":"J Inflamm Res"},{"key":"12092_CR6","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1136\/gutjnl-2015-310861","volume":"65","author":"MA Jackson","year":"2016","unstructured":"Jackson MA, Goodrich JK, Maxan M-E, Freedberg DE, Abrams JA, Poole AC, Sutter JL, Welter D, Ley RE, Bell JT (2016) Proton pump inhibitors alter the composition of the gut microbiota. Gut 65:749\u2013756","journal-title":"Gut"},{"key":"12092_CR7","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1136\/gutjnl-2015-310376","volume":"65","author":"F Imhann","year":"2016","unstructured":"Imhann F, Bonder MJ, Vila AV, Fu J, Mujagic Z, Vork L, Tigchelaar EF, Jankipersadsing SA, Cenit MC, Harmsen HJ (2016) Proton pump inhibitors affect the gut microbiome. Gut 65:740\u2013748","journal-title":"Gut"},{"key":"12092_CR8","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.cgh.2009.12.022","volume":"8","author":"L Lombardo","year":"2010","unstructured":"Lombardo L, Foti M, Ruggia O, Chiecchio A (2010) Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy. Clin Gastroenterol Hepatol 8:504\u2013508","journal-title":"Clin Gastroenterol Hepatol"},{"key":"12092_CR9","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/j.1365-2362.2010.02419.x","volume":"41","author":"D Compare","year":"2011","unstructured":"Compare D, Pica L, Rocco A, De Giorgi F, Cuomo R, Sarnelli G, Romano M, Nardone G (2011) Effects of long-term PPI treatment on producing bowel symptoms and SIBO. Eur J Clin Invest 41:380\u2013386","journal-title":"Eur J Clin Invest"},{"key":"12092_CR10","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1111\/apt.12304","volume":"37","author":"C Jacobs","year":"2013","unstructured":"Jacobs C, Coss Adame E, Attaluri A, Valestin J, Rao S (2013) Dysmotility and proton pump inhibitor use are independent risk factors for small intestinal bacterial and\/or fungal overgrowth. Aliment Pharmacol Ther 37:1103\u20131111","journal-title":"Aliment Pharmacol Ther"},{"key":"12092_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-020-08229-5","author":"JJ Haworth","year":"2021","unstructured":"Haworth JJ, Boyle N, Vales A, Hobson AR (2021) The prevalence of intestinal dysbiosis in patients referred for antireflux surgery. Surg Endosc. https:\/\/doi.org\/10.1007\/s00464-020-08229-5","journal-title":"Surg Endosc"},{"key":"12092_CR12","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/j.1572-0241.2004.04081.x","volume":"99","author":"SJ Spechler","year":"2004","unstructured":"Spechler SJ (2004) The management of patients who have \u201cfailed\u201d antireflux surgery. Am J Gastroenterol 99:552\u2013561","journal-title":"Am J Gastroenterol"},{"key":"12092_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.51666\/fs.2022.2.e2","volume":"2","author":"KY Song","year":"2022","unstructured":"Song KY (2022) Complications after antireflux surgery (ARS) and their management. Foregut Surg 2:1\u20137","journal-title":"Foregut Surg"},{"key":"12092_CR14","volume-title":"P232 Excessive belching in GERD: supragastric belching or small intestinal bacterial overgrowth?","author":"J Haworth","year":"2021","unstructured":"Haworth J, Vales A, Boyle N, Hobson A (2021) P232 Excessive belching in GERD: supragastric belching or small intestinal bacterial overgrowth? BMJ Publishing Group, UK"},{"key":"12092_CR15","doi-asserted-by":"publisher","first-page":"94","DOI":"10.4174\/astr.2018.95.2.94","volume":"95","author":"J-M Park","year":"2018","unstructured":"Park J-M, Chi K-C (2018) Antireflux surgery is equally beneficial in nonerosive and erosive gastroesophageal reflux disease. Ann Surg Treat Res 95:94\u201399","journal-title":"Ann Surg Treat Res"},{"key":"12092_CR16","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1097\/MCG.0000000000002031","volume":"59","author":"J Xu","year":"2024","unstructured":"Xu J, Qu Q, Yang Y, Yang J, Fang T, Yin J, Mo Q, Wu Z, Zeng L, He H (2024) The lactulose breath test can predict refractory gastroesophageal reflux disease by measuring bacterial overgrowth in the small intestine. J Clin Gastroenterol 59:448","journal-title":"J Clin Gastroenterol"},{"key":"12092_CR17","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1046\/j.1365-2168.1998.00505.x","volume":"85","author":"B Wijnhoven","year":"1998","unstructured":"Wijnhoven B, Salet G, Roelofs J, Smout A, Akkermans L, Gooszen H (1998) Function of the proximal stomach after Nissen fundoplication. J Br Surg 85:267\u2013271+","journal-title":"J Br Surg"},{"key":"12092_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1572-0241.2003.07189.x","volume":"98","author":"MA Lindeboom","year":"2003","unstructured":"Lindeboom MA, Ringers J, Straathof J-WA, Van Rijn PJ, Neijenhuis P, Masclee AA (2003) Effect of laparoscopic partial fundoplication on reflux mechanisms. Am J Gastroenterol 98:29\u201334","journal-title":"Am J Gastroenterol"},{"key":"12092_CR19","doi-asserted-by":"publisher","first-page":"6017","DOI":"10.3390\/jcm11206017","volume":"11","author":"B Skrzyd\u0142o-Radoma\u0144ska","year":"2022","unstructured":"Skrzyd\u0142o-Radoma\u0144ska B, Cukrowska B (2022) How to recognize and treat small intestinal bacterial overgrowth? J Clin Med 11:6017","journal-title":"J Clin Med"},{"key":"12092_CR20","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/j.1572-0241.2006.00458.x","volume":"101","author":"AI Sharara","year":"2006","unstructured":"Sharara AI, Aoun E, Abdul-Baki H, Mounzer R, Sidani S, ElHajj I (2006) A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence. Am J Gastroenterol 101:326\u2013333","journal-title":"Am J Gastroenterol"},{"key":"12092_CR21","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1056\/NEJMoa1004409","volume":"364","author":"M Pimentel","year":"2011","unstructured":"Pimentel M, Lembo A, Chey WD, Zakko S, Ringel Y, Yu J, Mareya SM, Shaw AL, Bortey E, Forbes WP (2011) Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med 364:22\u201332","journal-title":"N Engl J Med"},{"key":"12092_CR22","first-page":"412","volume":"98","author":"M Pimentel","year":"2003","unstructured":"Pimentel M, Chow EJ, Lin HC (2003) Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome: a double-blind, randomized, placebo-controlled study. Am J Gastroenterol 98:412\u2013419","journal-title":"Am J Gastroenterol"},{"key":"12092_CR23","doi-asserted-by":"publisher","first-page":"16","DOI":"10.5056\/jnm19113","volume":"26","author":"G Losurdo","year":"2020","unstructured":"Losurdo G, Leandro G, Ierardi E, Perri F, Barone M, Principi M, Di Leo A (2020) Breath tests for the non-invasive diagnosis of small intestinal bacterial overgrowth: a systematic review with meta-analysis. J Neurogastroenterol Motil 26:16","journal-title":"J Neurogastroenterol Motil"},{"key":"12092_CR24","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s43440-023-00489-x","volume":"75","author":"A Kiecka","year":"2023","unstructured":"Kiecka A, Szczepanik M (2023) Proton pump inhibitor-induced gut dysbiosis and immunomodulation: current knowledge and potential restoration by probiotics. Pharmacol Rep 75:791\u2013804","journal-title":"Pharmacol Rep"},{"key":"12092_CR25","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1111\/1462-2920.12285","volume":"16","author":"I Amir","year":"2014","unstructured":"Amir I, Konikoff FM, Oppenheim M, Gophna U, Half EE (2014) Gastric microbiota is altered in oesophagitis and B arrett\u2019s oesophagus and further modified by proton pump inhibitors. Environ Microbiol 16:2905\u20132914","journal-title":"Environ Microbiol"},{"key":"12092_CR26","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.cgh.2012.12.011","volume":"11","author":"WK Lo","year":"2013","unstructured":"Lo WK, Chan WW (2013) Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta-analysis. Clin Gastroenterol Hepatol 11:483\u2013490","journal-title":"Clin Gastroenterol Hepatol"},{"key":"12092_CR27","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1136\/gut.23.12.1048","volume":"23","author":"R Stockbrugger","year":"1982","unstructured":"Stockbrugger R, Cotton P, Eugenides N, Bartholomew B, Hill M, Walters C (1982) Intragastric nitrites, nitrosamines, and bacterial overgrowth during cimetidine treatment. Gut 23:1048\u20131054","journal-title":"Gut"},{"key":"12092_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002836","volume":"3","author":"AF Andersson","year":"2008","unstructured":"Andersson AF, Lindberg M, Jakobsson H, B\u00e4ckhed F, Nyr\u00e9n P, Engstrand L (2008) Comparative analysis of human gut microbiota by barcoded pyrosequencing. PLoS ONE 3:e2836","journal-title":"PLoS ONE"},{"key":"12092_CR29","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1073\/pnas.0506655103","volume":"103","author":"EM Bik","year":"2006","unstructured":"Bik EM, Eckburg PB, Gill SR, Nelson KE, Purdom EA, Francois F, Perez-Perez G, Blaser MJ, Relman DA (2006) Molecular analysis of the bacterial microbiota in the human stomach. Proc Natl Acad Sci U S A 103:732\u2013737","journal-title":"Proc Natl Acad Sci U S A"},{"key":"12092_CR30","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.4240\/wjgs.v15.i6.1138","volume":"15","author":"L Li","year":"2023","unstructured":"Li L, Zhang X-Y, Yu J-S, Zhou H-M, Qin Y, Xie W-R, Ding W-J, He X-X (2023) Ability of lactulose breath test results to accurately identify colorectal polyps through the measurement of small intestine bacterial overgrowth. World J Gastrointest Surg 15:1138","journal-title":"World J Gastrointest Surg"},{"key":"12092_CR31","doi-asserted-by":"publisher","first-page":"2681791","DOI":"10.1155\/2020\/2681791","volume":"2020","author":"EE Ziganshina","year":"2020","unstructured":"Ziganshina EE, Sagitov II, Akhmetova RF, Saleeva GT, Kiassov AP, Gogoleva NE, Shagimardanova EI, Ziganshin AM (2020) Comparison of the microbiota and inorganic anion content in the saliva of patients with gastroesophageal reflux disease and gastroesophageal reflux disease-free individuals. Biomed Res Int 2020:2681791","journal-title":"Biomed Res Int"},{"key":"12092_CR32","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.gpb.2018.12.004","volume":"17","author":"Y-C Shi","year":"2019","unstructured":"Shi Y-C, Cai S-T, Tian Y-P, Zhao H-J, Zhang Y-B, Chen J, Ren R-R, Luo X, Peng L-H, Sun G (2019) Effects of proton pump inhibitors on the gastrointestinal microbiota in gastroesophageal reflux disease. Genomics Proteomics Bioinformatics 17:52\u201363","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"12092_CR33","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1111\/apt.12317","volume":"37","author":"K Blackett","year":"2013","unstructured":"Blackett K, Siddhi S, Cleary S, Steed H, Miller M, Macfarlane S, Macfarlane G, Dillon J (2013) Oesophageal bacterial biofilm changes in gastro-oesophageal reflux disease, Barrett\u2019s and oesophageal carcinoma: association or causality? Aliment Pharmacol Ther 37:1084\u20131092","journal-title":"Aliment Pharmacol Ther"},{"key":"12092_CR34","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/jgh.16013","volume":"38","author":"S Bamba","year":"2023","unstructured":"Bamba S, Imai T, Sasaki M, Ohno M, Yoshida S, Nishida A, Takahashi K, Inatomi O, Andoh A (2023) Altered gut microbiota in patients with small intestinal bacterial overgrowth. J Gastroenterol Hepatol 38:61\u201369","journal-title":"J Gastroenterol Hepatol"},{"key":"12092_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.gande.2024.07.001","author":"G Wang","year":"2024","unstructured":"Wang G (2024) Advancement of the relationship between esophageal microorganisms and esophageal diseases. Gastroenterology & Endoscopy. https:\/\/doi.org\/10.1016\/j.gande.2024.07.001","journal-title":"Gastroenterology & Endoscopy"}],"container-title":["Surgical Endoscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-025-12092-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00464-025-12092-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-025-12092-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T18:36:19Z","timestamp":1763145379000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00464-025-12092-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,28]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["12092"],"URL":"https:\/\/doi.org\/10.1007\/s00464-025-12092-7","relation":{},"ISSN":["0930-2794","1432-2218"],"issn-type":[{"value":"0930-2794","type":"print"},{"value":"1432-2218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,28]]},"assertion":[{"value":"10 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Drs. Naveed Chaudhry, Sven E Eriksson Inanc S. Sarici, Kelsi J. Swanson, Sarah Hanuschock, Ann M. DeWitt, Ping Zheng and Shahin Ayazi have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}